🚚 Free shipping on all orders above $299 · 30 days money back guarantee · Helpline +1 251-332-4105

Imiquimod Sachet

$147.00$4.90 per sachet · 30 sachets

Imiquad Cream (0.25gm Each) treats genital warts & actinic keratosis. Buy online at a cheap price on PharmeasyBank. Fast & secure delivery in the US, UK & Australia.

Choose pack sizePrice per sachet shown

Want to order in bulk / B2B price?

Tracked, discreet delivery

Ships in discreet packaging with a tracking number. Free shipping on orders above $299.

30 days money back guarantee

Damaged, missing or only part of your order arrived? Choose a new package or a full refund.

Questions before you order?

Call +1 251-332-4105 or email order@pharmeasybank.com.

SECURE CHECKOUT
DISCOVER
MasterCard
VISA

Share

What Is Imiquimod Sachet?

Imiquimod Sachet contains imiquimod, a topical immune response modifier used to treat certain skin conditions.

Imiquimod works differently from conventional antibiotics, antifungal creams and direct-acting antiviral medicines.

Instead of directly destroying bacteria or viruses, it stimulates local immune responses that help the body recognize and respond to abnormal or virus-affected skin cells.

Imiquimod activates toll-like receptor 7 (TLR7), an important component of the innate immune system.

This promotes the production of immune signaling molecules, including interferon-alpha and certain inflammatory cytokines.

These immune responses contribute to its therapeutic effects.

Imiquimod is used for selected conditions such as external genital and perianal warts, actinic keratosis and certain superficial basal cell carcinomas.

The approved indications vary depending on the strength and country-specific product labeling.

For example, imiquimod 5% cream is used for selected superficial basal cell carcinomas in certain jurisdictions, whereas this indication should not automatically be assigned to every imiquimod formulation.

The medicine is supplied in sachets designed to provide a convenient single-use quantity of cream.

The amount applied depends on the affected area and prescribed treatment regimen.

Imiquimod may cause visible local skin reactions such as redness, irritation, swelling, crusting or erosion.

These reactions reflect local inflammatory activity but do not necessarily indicate that treatment is working better.

Severe reactions require medical assessment.

Important: Imiquimod does not eliminate human papillomavirus (HPV) from the body or guarantee that genital warts will never return.

How Does Imiquimod Sachet Work?

1. Activates Toll-Like Receptor 7

Imiquimod stimulates TLR7, a receptor involved in recognizing immune threats.

2. Stimulates Local Immune Responses

It promotes activation of immune cells within the treated skin.

3. Increases Interferon Production

Imiquimod encourages the production of interferon-alpha and other immune signaling molecules.

4. Promotes Cytokine Release

It stimulates cytokines involved in local inflammatory and immune responses.

5. Supports Immune Recognition of HPV-Affected Cells

In external genital warts, imiquimod helps the immune system respond to affected skin.

6. Targets Abnormal Skin Cell Activity

In approved precancerous and superficial skin cancer indications, local immune activation contributes to the destruction of abnormal cells.

7. Supports Clearance of Visible Lesions

Appropriate treatment may lead to partial or complete clearance of selected lesions.

8. Produces a Gradual Treatment Response

Clinical improvement usually develops over weeks rather than immediately after application.

Important: Imiquimod is not a conventional chemical wart remover. Its therapeutic action depends on the local immune response.

Uses of Imiquimod Sachet

1. External Genital Warts

Imiquimod is used to treat external genital warts caused by certain types of human papillomavirus.

It may be prescribed for visible warts affecting external genital skin.

2. External Perianal Warts

Imiquimod may be used for external warts around the anus.

It must not be applied inside the anal canal unless a specialist has prescribed a specifically appropriate treatment.

3. Actinic Keratosis

Certain imiquimod formulations are approved for actinic keratosis, a precancerous skin condition associated with cumulative ultraviolet exposure.

4. Superficial Basal Cell Carcinoma

Imiquimod 5% cream may be used for selected biopsy-confirmed superficial basal cell carcinomas when the patient and lesion meet the approved treatment criteria.

It is not appropriate for every type of skin cancer.

Imiquimod supports immune-mediated treatment of certain HPV-associated external skin lesions.

6. Immune-Mediated Dermatological Treatment

Imiquimod may be selected when a dermatologist considers local immune response modification appropriate.

7. Specialist-Directed Off-Label Dermatological Treatment

Dermatologists may sometimes prescribe imiquimod for other conditions.

Such uses require individual assessment and should not be presented as established approved indications.

Important: Do not advertise imiquimod as a general cure for HPV, cervical cancer, melanoma, all skin cancers or sexually transmitted infections.

How to Use Imiquimod Sachet

Imiquimod should be applied only according to the prescribed treatment schedule.

General Application Instructions

  1. Wash your hands before application.
  2. Clean the affected skin gently with mild soap and water.
  3. Allow the skin to dry completely.
  4. Open a new sachet immediately before use.
  5. Apply a thin layer of cream to the prescribed external skin area.
  6. Rub gently until the cream is no longer visible.
  7. Avoid applying excessive quantities.
  8. Leave the cream on for the prescribed period.
  9. Do not cover the treated area with an airtight dressing unless specifically instructed.
  10. Wash your hands after application.
  11. After the prescribed contact period, wash the treated area with mild soap and water.
  12. Discard the opened sachet according to the product instructions.
  13. Avoid contact with the eyes, lips and internal mucous membranes.
  14. Do not apply to severely broken or unhealed skin unless specifically directed.
  15. Follow the exact treatment schedule prescribed for the condition.

Dosage and Application Information

IndicationCommon Regimen for Imiquimod 5% Cream
External Genital/Perianal WartsThree Times Weekly, Typically Before Bedtime
Wart Treatment Contact TimeApproximately 6–10 Hours
Maximum Wart Treatment DurationUp to 16 Weeks
Actinic KeratosisCommonly Twice Weekly for 16 Weeks Under Certain Approved 5% Regimens
Actinic Keratosis Contact TimeApproximately 8 Hours
Superficial Basal Cell CarcinomaCommonly Five Times Weekly for 6 Weeks in Eligible Patients
Superficial Basal Cell Carcinoma Contact TimeApproximately 8 Hours
3.75% FormulationsDifferent Application Schedules; Follow Specific Product Label
Application QuantityThin Layer to Prescribed Treatment Area
RouteExternal Topical Application

Important: These examples describe selected labeled regimens for imiquimod 5% cream, not a universal schedule for all sachets. Treatment schedules vary by formulation, indication and jurisdiction.

Can Imiquimod Be Applied Every Day?

Only when the prescribed product and indication require daily application.

For example, common 5% genital wart regimens are not daily.

Can Imiquimod Be Applied to the Face?

Certain approved actinic keratosis and superficial basal cell carcinoma treatment regimens may involve facial skin.

Application should follow a dermatologist’s instructions.

Can Imiquimod Be Used on Open Wounds?

Generally, treatment should not begin on skin that has not healed from previous procedures or injuries unless a healthcare professional specifically advises otherwise.

Can Imiquimod Be Used Inside the Vagina or Anus?

No. Standard topical imiquimod sachets are intended for external skin use.

Can Imiquimod Be Used With Other Skin Creams?

Other topical medicines may increase irritation or interfere with treatment.

Use combinations only when directed by a healthcare professional.

What If an Application Is Missed?

Follow the product-specific missed-application instructions.

Do not apply extra cream or increase the frequency to compensate.

What If Too Much Cream Is Applied?

Excessive application may cause severe local inflammation and increase the risk of systemic adverse effects.

Wash off excess cream and seek medical advice if a significant reaction develops.

How Long Does Imiquimod Sachet Take to Work?

Treatment response depends on the condition, formulation and individual immune response.

During the First Few Applications

Redness, irritation or other local skin reactions may develop.

After Several Weeks

Visible lesions may begin to decrease in size or number.

During Genital Wart Treatment

Clearance may occur over several weeks, and treatment may continue for up to 16 weeks under common 5% regimens.

During Actinic Keratosis Treatment

Response is generally assessed after completion of the prescribed course and an appropriate healing period.

During Superficial Basal Cell Carcinoma Treatment

The treated area requires follow-up examination to confirm clinical response.

Important: Visible improvement does not always establish complete lesion clearance, particularly when treating superficial basal cell carcinoma.

Common Side Effects

Possible side effects include:

  • Skin Redness
  • Itching
  • Burning Sensation
  • Local Pain
  • Skin Irritation
  • Swelling
  • Dryness
  • Scaling
  • Flaking
  • Crusting
  • Scabbing
  • Skin Erosion
  • Tenderness
  • Changes in Skin Color
  • Headache
  • Fatigue
  • Flu-Like Symptoms

Local skin reactions are common and may become significant during treatment.

Serious Side Effects

Seek medical attention if any of the following occur:

  • Severe skin erosion
  • Extensive ulceration
  • Severe swelling
  • Intense or persistent pain
  • Difficulty urinating due to genital swelling
  • Severe allergic reactions
  • Significant flu-like symptoms
  • Fainting or severe weakness
  • Signs of serious secondary skin infection
  • Severe reactions involving mucous membranes

Important Serious Risks

1. Severe Local Inflammatory Reactions

Imiquimod can cause intense redness, swelling, erosion and ulceration.

2. Skin Pigmentation Changes

Hypopigmentation or hyperpigmentation may occur and can sometimes persist.

3. Flu-Like Symptoms

Fever, fatigue, muscle pain or malaise may occur.

4. Severe Genital Skin Reactions

Marked inflammation may cause pain, swelling and difficulty with normal activities.

5. Secondary Skin Infection

Damaged or eroded skin may become infected.

6. Allergic Reactions

Rare severe hypersensitivity reactions require immediate medical attention.

7. Autoimmune or Inflammatory Disease Exacerbation

Immune stimulation may worsen certain inflammatory or autoimmune skin conditions.

Contraindications & Precautions

1. Allergy to Imiquimod

Patients with known hypersensitivity to imiquimod or formulation ingredients should not use the medicine.

2. External Use Only

Do not swallow or apply inside body cavities.

3. Severe Skin Irritation

Treatment may require interruption if severe local reactions develop.

4. Broken or Unhealed Skin

Avoid applying to unhealed wounds unless specifically directed.

5. Genital and Perianal Application

Use only on external lesions and follow the prescribed treatment area.

6. Sexual Contact

For genital wart treatment, wash the cream off before sexual activity.

Imiquimod cream may weaken condoms and diaphragms while present on the skin.

7. HPV Transmission

Treatment of visible warts does not necessarily prevent HPV transmission.

8. Sun Exposure

Patients treated for actinic keratosis or skin cancer should follow sun-protection recommendations.

9. Skin Cancer Diagnosis

Superficial basal cell carcinoma should be appropriately diagnosed, generally by biopsy, before treatment.

10. Treatment Follow-Up

Patients treated for superficial basal cell carcinoma require clinical follow-up to assess clearance and recurrence.

11. Pregnancy

Use during pregnancy should be based on a healthcare professional’s assessment of potential benefits and risks.

12. Breastfeeding

Discuss use during breastfeeding with a healthcare professional.

Avoid infant contact with treated skin.

13. Pediatric Use

Approved pediatric ages vary by indication and formulation.

14. Autoimmune Disorders

Patients with autoimmune or inflammatory conditions should inform their healthcare professional.

15. Immunosuppression

Patients with weakened immune systems may respond differently and require specialist guidance.

16. Concurrent Topical Treatments

Other topical products may increase irritation.

17. Application Frequency

Applying more often than prescribed can increase toxicity without improving treatment outcomes.

18. Medical Monitoring

Healthcare professionals may assess:

  • Lesion Size
  • Lesion Number
  • Treatment Response
  • Local Redness
  • Swelling
  • Skin Erosion
  • Ulceration
  • Pain
  • Itching
  • Secondary Infection
  • Pigmentation Changes
  • Flu-Like Symptoms
  • Application Technique
  • Treatment Adherence
  • Skin Healing
  • HPV-Related Wart Recurrence
  • Skin Cancer Clearance When Applicable
  • Need for Treatment Interruption
  • Overall Skin Condition

Potential Therapeutic Advantages

  • Topical Immune Response Modification.
  • Toll-Like Receptor 7 Activation.
  • Local Immune Stimulation.
  • External Genital Wart Treatment.
  • External Perianal Wart Treatment.
  • Actinic Keratosis Treatment.
  • Selected Superficial Basal Cell Carcinoma Treatment.
  • Non-Surgical Treatment Option for Selected Lesions.
  • Targeted Topical Application.
  • Single-Use Sachet Packaging.
  • Dermatologist-Supervised Therapy.
  • Established Immunomodulatory Mechanism.

Disadvantages / Limitations

  • Skin Redness.
  • Burning Sensation.
  • Itching.
  • Local Pain.
  • Swelling.
  • Crusting.
  • Skin Erosion.
  • Possible Ulceration.
  • Skin Pigmentation Changes.
  • Flu-Like Symptoms.
  • Requires Careful Application.
  • Requires Condition-Specific Scheduling.
  • Treatment May Take Several Weeks.
  • Genital Warts May Recur.
  • Does Not Eradicate HPV.
  • Not Suitable for Every Skin Cancer.
  • Requires Follow-Up.
  • Requires Medical Supervision.

Important Notes

Generic Name: Imiquimod.

Common Strength: 5% w/w.

Alternative Strength: 3.75%, Depending on Product.

Drug Class: Immune Response Modifier.

Therapeutic Category: Dermatology / Immunomodulator.

Primary Uses: External Genital Warts, Actinic Keratosis and Selected Superficial Basal Cell Carcinomas.

Mechanism of Action: Toll-Like Receptor 7 Activation.

Route: Topical.

Dosage Form: Cream Sachet.

Internal Application: Not Permitted.

Major Local Risk: Severe Skin Inflammation.

Treatment Duration: Indication-Specific.

Medical Supervision: Required.

Storage: Follow Original Packaging Instructions.

Frequently Asked Questions

1. What is Imiquimod Sachet used for?

Imiquimod cream is used for selected external genital and perianal warts, actinic keratosis and certain superficial basal cell carcinomas.

2. Is Imiquimod an antiviral medicine?

It is an immune response modifier rather than a conventional direct-acting antiviral.

3. How does Imiquimod work?

It activates local immune responses through toll-like receptor 7.

4. Is Imiquimod used for genital warts?

Yes. Certain formulations are approved for external genital and perianal warts.

5. Can Imiquimod cure HPV permanently?

No. Treatment may clear visible warts but does not guarantee elimination of HPV or prevent recurrence.

6. Is Imiquimod used for actinic keratosis?

Yes. Certain formulations are approved for actinic keratosis.

7. Can Imiquimod treat skin cancer?

Imiquimod 5% may be used for selected biopsy-confirmed superficial basal cell carcinomas. It is not suitable for all skin cancers.

8. How often should Imiquimod be applied?

Application frequency depends on the formulation and condition being treated.

Product DetailsInformation
Product NameImiquimod Sachet
Generic NameImiquimod
Active IngredientImiquimod
StrengthCommonly 5% w/w; 3.75% Formulations Also Exist
Dosage FormTopical Cream in Single-Use Sachet
Drug ClassImmune Response Modifier
Therapeutic CategoryDermatology / Topical Immunomodulator
Primary UsesExternal Genital and Perianal Warts, Actinic Keratosis, Selected Superficial Basal Cell Carcinomas
Mechanism of ActionActivation of Local Innate Immune Responses
Route of AdministrationTopical Application
Application AreaAffected External Skin
Application FrequencyDepends on Strength and Indication
Treatment DurationDepends on the Skin Condition and Clinical Response
Brand ReferenceAldara (5%); Zyclara (3.75%)
ManufacturerVerify Original Packaging
Pack SizeVerify Original Packaging
Prescription StatusPrescription Medicine in Many Jurisdictions
StorageFollow Manufacturer Instructions; Do Not Freeze Unless Labeling Permits
Medical SupervisionDermatologist or Qualified Healthcare Professional
Pack sizes30 sachets, 60 sachets, 90 sachets
Bulk / B2B price inquiry

Tell us what you need and we’ll reply by email.